Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

NCT01163487 is registered in ClinicalTrials.gov with Daniel T. Chang as lead sponsor.

NCT NCT01163487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01163487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
Lead sponsor
Daniel T. Chang
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2010
Completion date
February 29, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, head and neck cancers